These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 33945031)
1. LINC02308 promotes the progression of glioma through activating mTOR/AKT-signaling pathway by targeting miR-30e-3p/TM4SF1 axis. Gao X; Wang X; He H; Cao Y Cell Biol Toxicol; 2022 Apr; 38(2):223-236. PubMed ID: 33945031 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer. Ma T; Chen H; Wang P; Yang N; Bao J Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162 [No Abstract] [Full Text] [Related]
3. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway. Li C; Feng S; Chen L Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913 [TBL] [Abstract][Full Text] [Related]
4. TM4SF1 involves in miR-1-3p/miR-214-5p-mediated inhibition of the migration and proliferation in keloid by regulating AKT/ERK signaling. Xu M; Sun J; Yu Y; Pang Q; Lin X; Barakat M; Lei R; Xu J Life Sci; 2020 Aug; 254():117746. PubMed ID: 32376266 [TBL] [Abstract][Full Text] [Related]
5. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA SNHG6 promotes glioma tumorigenesis by sponging miR-101-3p. Meng Q; Yang BY; Liu B; Yang JX; Sun Y Int J Biol Markers; 2018 May; 33(2):148-155. PubMed ID: 29799357 [TBL] [Abstract][Full Text] [Related]
7. M2 macrophage-derived exosomal microRNAs inhibit cell migration and invasion in gliomas through PI3K/AKT/mTOR signaling pathway. Yao J; Wang Z; Cheng Y; Ma C; Zhong Y; Xiao Y; Gao X; Li Z J Transl Med; 2021 Mar; 19(1):99. PubMed ID: 33676540 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA KB-1460A1.5 inhibits glioma tumorigenesis via miR-130a-3p/TSC1/mTOR/YY1 feedback loop. Xu L; Wu Q; Yan H; Shu C; Fan W; Tong X; Li Q Cancer Lett; 2022 Jan; 525():33-45. PubMed ID: 34728310 [TBL] [Abstract][Full Text] [Related]
9. MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma. Liu PJ; Ye YX; Wang YX; Du JX; Pan YH; Fang XB Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6612-6620. PubMed ID: 31378903 [TBL] [Abstract][Full Text] [Related]
10. miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells. Li XT; Wang HZ; Wu ZW; Yang TQ; Zhao ZH; Chen GL; Xie XS; Li B; Wei YX; Huang YL; Zhou YX; Du ZW Cell Mol Neurobiol; 2015 Jul; 35(5):679-87. PubMed ID: 25662849 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway. Shen L; Sun C; Li Y; Li X; Sun T; Liu C; Zhou Y; Du Z Tumour Biol; 2015 Sep; 36(9):6929-38. PubMed ID: 25854175 [TBL] [Abstract][Full Text] [Related]
12. circKIF4A promotes tumorogenesis of glioma by targeting miR-139-3p to activate Wnt5a signaling. Huo LW; Wang YF; Bai XB; Zheng HL; Wang MD Mol Med; 2020 Apr; 26(1):29. PubMed ID: 32268875 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway. Lv X; Li CY; Han P; Xu XY Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835 [TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor miR-361-3p inhibits prostate cancer progression through Gli1 and AKT/mTOR signaling pathway. Wang S; Huang X; Zhang G; Chen Z; Guan H; Zhou W Cell Signal; 2024 Feb; 114():110998. PubMed ID: 38048859 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway. Li YJ; Wang Y; Wang YY J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801 [TBL] [Abstract][Full Text] [Related]
16. MiR-92a-3p Promotes the Malignant Progression of Hepatocellular Carcinoma by Mediating the PI3K/AKT/mTOR Signaling Pathway. Wang L; Cui M; Qu F; Cheng D; Yu J; Tang Z; Cheng L; Wei Y; Wu X; Liu X Curr Pharm Des; 2021; 27(29):3244-3250. PubMed ID: 34126886 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-30e-3p inhibits glioma development and promotes drug sensitivity to temozolomide treatment via targeting canopy FGF signaling regulator 2. Gao K; Wang T; Qiao Y; Cui B Cell Cycle; 2021 Nov; 20(22):2361-2371. PubMed ID: 34657557 [TBL] [Abstract][Full Text] [Related]
18. miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2. Chen X; Hao B; Han G; Liu Y; Dai D; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J J Cell Biochem; 2015 Feb; 116(2):225-32. PubMed ID: 25160587 [TBL] [Abstract][Full Text] [Related]
19. Role of TM4SF1 in regulating breast cancer cell migration and apoptosis through PI3K/AKT/mTOR pathway. Sun Y; Xu Y; Xu J; Lu D; Wang J Int J Clin Exp Pathol; 2015; 8(8):9081-8. PubMed ID: 26464650 [TBL] [Abstract][Full Text] [Related]
20. miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway. Zhang Y; Zhang D; Lv J; Wang S; Zhang Q Biochem Biophys Res Commun; 2018 Sep; 503(4):2459-2465. PubMed ID: 29969630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]